The Next Great Frontier: COVID Vaccine Development will explore the challenges and the possibilities of vaccine development, such as the unprecedented speed at which COVID vaccine development is advancing; the expected challenges such as efficacy, public hesitancy, and access; and an introduction of Human Immunomics Initiative (HII). After a brief welcome and opening remarks, expert panelists will discuss health equity and vaccine development, the role of the immune system in vaccine development, the race to develop a vaccine, and vaccine hesitancy. All Harvard Chan alumni are invited and encouraged to tune in.
Featured Panelists
Jaap Goudsmit, MD, PhD
Adjunct Professor of Epidemiology and Infectious Diseases
Senior Vice President and CSO, Human Vaccine Project
Albert Hofman, MD, PhD
Stephen B. Kay Family Professor of Public Health and Clinical Epidemiology
Chair, Department of Epidemiology
Michael Mina, MD, PhD
Assistant Professor in Immunology and Infectious Disease at Harvard T. H. Chan School of Public Health and a core member of the Center for Communicable Disease Dynamics (CCDD). He is also the Associate Medical Director in Clinical Microbiology (molecular diagnostics) in the Department of Pathology at Brigham and Women’s Hospital, Harvard Medical School
Julia Wu, SD '13
Research Scientist, Department of Epidemiology
Moderated by Dr. Sri Sastry, MPH '90
Ophthalmologist, Bethesda Retina, LLC
Chair, Harvard Chan Board of Dean’s Advisors
